Skip to main content

Peer Review reports

From: Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma

Original Submission
4 Jan 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
8 Mar 2022 Reviewed Reviewer Report - Jinhui Liu
19 Mar 2022 Reviewed Reviewer Report
4 Apr 2022 Author responded Author comments - Yafeng Wan
Resubmission - Version 6
4 Apr 2022 Submitted Manuscript version 6
7 Apr 2022 Author responded Author comments - Yafeng Wan
Resubmission - Version 7
7 Apr 2022 Submitted Manuscript version 7
14 Apr 2022 Reviewed Reviewer Report - Jinhui Liu
28 Apr 2022 Reviewed Reviewer Report
5 May 2022 Author responded Author comments - Yafeng Wan
Resubmission - Version 8
5 May 2022 Submitted Manuscript version 8
8 May 2022 Author responded Author comments - Yafeng Wan
Resubmission - Version 9
8 May 2022 Submitted Manuscript version 9
Publishing
12 May 2022 Editorially accepted
10 Jun 2022 Article published 10.1186/s12885-022-09662-6

You can find further information about peer review here.

Back to article page